Another tiny bit of self-promotion – a new publication published today. Stems essentially from a literature review I did after clawing through ECASS-III and noting that 12 of the 14 investigators were paid, sponsored, or employed by the manufacturers of alteplase – which muddied my estimation of the reliability of the conclusions. Turns out, ECASS-III wasn’t the only one….
“Pharmaceutical Sponsorship Bias Influences Thrombolytic Literature in Acute Ischemic Stroke”